In this article, we are going to take a look at where Twist Bioscience Corporation (NASDAQ:TWST) stands against the other stocks in Cathie Wood’s portfolio. Cathie Wood is one of Wall Street’s ...

Twist Bioscience (TWST) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Twist Bioscience Corporation (NASDAQ:TWST), a player in the U.S. Life Science Tools & Diagnostics sector, has been making strides in operational efficiency and product development. This comprehensive ...

Barclays analyst Luke Sergott maintained a Buy rating on Twist Bioscience (TWST – Research Report) today and set a price target of $52.00. The company’s shares closed last Friday at $52.37.

We’re starting the fiscal year strong, demonstrating our unwavering commitment to progressing toward adjusted EBITDA breakeven,” said Emily Leproust, CEO and co-founder of Twist Bioscience (TWST).

Ratings for Twist Bioscience (NASDAQ:TWST) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ...

In this article, we are going to take a look at where Twist Bioscience Corporation (NASDAQ:TWST) stands against the other stocks in Cathie Wood’s portfolio. Cathie Wood is one of Wall Street’s ...